BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 98,967 Value ($000) $127 Avg Close — Range —
Q1 2024
Shares 22,770 Value ($000) $64 Avg Close — Range —
Q4 2023
Shares 19,200 Value ($000) $57 Avg Close — Range —
Q3 2023
Shares 132,874 Value ($000) $336 Avg Close — Range —
Q2 2023
Shares 144,046 Value ($000) $959 Avg Close — Range —
Q1 2023
Shares 163,650 Value ($000) $3,054 Avg Close — Range —
Q4 2022
Shares 53,424 Value ($000) $1,148 Avg Close — Range —
Q3 2022
Shares 93,509 Value ($000) $1 Avg Close — Range —
Q2 2022
Shares 72,674 Value ($000) $1 Avg Close — Range —
Q1 2022
Shares 68,748 Value ($000) $1,437 Avg Close — Range —
Q4 2021
Shares 49,734 Value ($000) $1,011 Avg Close — Range —
Q3 2021
Shares 35,969 Value ($000) $1,091 Avg Close — Range —
Q2 2021
Shares 177,590 Value ($000) $5,160 Avg Close — Range —
Q1 2021
Shares 126,465 Value ($000) $5,458 Avg Close — Range —
Q4 2020
Shares 224,643 Value ($000) $10,379 Avg Close — Range —
Q3 2020
Shares 127,611 Value ($000) $5,533 Avg Close — Range —
Q2 2020
Shares 99,979 Value ($000) $5,300 Avg Close — Range —
Q1 2020
Shares 49,911 Value ($000) $1,116 Avg Close — Range —
Q2 2018
Shares 10,620 Value ($000) $98 Avg Close — Range —
Q1 2018
Shares 27,880 Value ($000) $285 Avg Close — Range —